Chromadex Corp [NASDAQ: CDXC] jumped around 2.37 points on Friday, while shares priced at $5.86 at the close of the session, up 67.91%.
Compared to the average trading volume of 268.00K shares, CDXC reached a trading volume of 37619501 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
What do top market gurus say about Chromadex Corp [CDXC]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CDXC shares is $6.92 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CDXC stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Oppenheimer have made an estimate for Chromadex Corp shares, keeping their opinion on the stock as Perform, with their previous recommendation back on August 16, 2022. While these analysts kept the previous recommendation, B. Riley Securities dropped their target price from $6 to $2.40. The new note on the price target was released on August 11, 2022, representing the official price target for Chromadex Corp stock. Previously, the target price had yet another raise to $7, while ROTH Capital analysts kept a Buy rating on CDXC stock.
The Average True Range (ATR) for Chromadex Corp is set at 0.33, with the Price to Sales ratio for CDXC stock in the period of the last 12 months amounting to 8.20. The Price to Book ratio for the last quarter was 12.96, with the Price to Cash per share for the same quarter was set at 0.25. Price to Free Cash Flow for CDXC in the course of the last twelve months was 189.31 with Quick ratio for the last quarter at 2.35.
How has CDXC stock performed recently?
Chromadex Corp [CDXC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 68.88. With this latest performance, CDXC shares gained by 68.88% in over the last four-week period, additionally plugging by 55.03% over the last 6 months – not to mention a rise of 340.60% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CDXC stock in for the last two-week period is set at 84.94, with the RSI for the last a single of trading hit 89.42, and the three-weeks RSI is set at 80.66 for Chromadex Corp [CDXC]. The present Moving Average for the last 50 days of trading for this stock 3.53, while it was recorded at 4.04 for the last single week of trading, and 2.97 for the last 200 days.
Chromadex Corp [CDXC]: Deeper insight into the fundamentals
Chromadex Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.35 and a Current Ratio set at 2.95.
Insider trade positions for Chromadex Corp [CDXC]
There are presently around $22.57%, or 34.93%% of CDXC stock, in the hands of institutional investors. The top three institutional holders of CDXC stocks are: VANGUARD GROUP INC with ownership of 3.39 million shares, which is approximately 4.5014%. BLACKROCK INC., holding 3.12 million shares of the stock with an approximate value of $$8.51 million in CDXC stocks shares; and BLACKROCK INC., currently with $$8.1 million in CDXC stock with ownership which is approximately 3.9453%.
